OBJECTIVE: Due to the poor results achieved on combination chemotherapy and the
unproven cost-effectiveness value of myeloablative therapy, the question has been raised; …

Not all children with neuroblastoma succumb to the disease.“Good-prognosis”,“intermediate-
prognosis” and “bad-prognosis” patients can now be defined; unfortunately, the latter …

The use of multimodality therapy including chemotherapy in the treatment of various stages
of neuroblastoma is based on the well-known aggressive nature and high mortality …

PURPOSE To define factors that influence outcome in children with localized but
unresectable neuroblastoma by retrospective investigation of response to therapy and …

Neuroblastoma is the most common extra-cranial solid tumor in children and has a
heterogeneous clinical presentation and course. Clinical and biologic features of this …

Management of neuroblastoma: a study of first- and second-line chemotherapy responses,
a single institution experience - PMC Back to Top Skip to main content NIH NLM Logo …

Background: Neuroblastoma in the adult is rare. No established therapeutic guidelines exist
for these patients and the literature on this issue is scant and contradictory. Materials and …

Background We previously reported that stage 3 neuroblastoma comprises (i) a low-risk
group including all infants (age 0–11 months) as well as older children with non-abdominal …

Between 1985 and 1999, 128 children with neuroblastoma were treated at the Royal
Alexandra Hospital for Children. The objective of this retrospective study was to report on a …

OBJECTIVE: To assess the outcome of children older than one year with neuroblastoma
treated at King Abdul-Aziz Medical City, Jeddah, Kingdom of Saudi Arabia. METHODS: We …